Qube Research & Technologies (QRT)
DNA icon

Qube Research & Technologies (QRT)’s Ginkgo Bioworks DNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-237,646
Closed -$2.33M – 3558
2024
Q4 		$2.33M Buy
237,646
+133,742
+129% +$1.15M ﹤0.01% 1819
2024
Q3 		$847K Sell
103,904
-283,904
-73% -$2.84M ﹤0.01% 2088
2024
Q2 		$5.19M Buy
+387,808
New +$11.6M 0.01% 1234
2023
Q2 		– Sell
-61,100
Closed -$3.25M – 2525
2023
Q1 		$3.25M Buy
+61,100
New +$3.87M 0.01% 803
2022
Q1 		– Sell
-276
Closed -$92K – 2559
2021
Q4 		$92K Buy
+276
New +$131K ﹤0.01% 2155

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s DNA Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Ginkgo Bioworks (DNA) in Q1 2025, closing a stake of 237,646 shares — an estimated $2.33M sold.

Qube Research & Technologies (QRT) first reported a position in DNA in Q4 2021 and held it in 5 quarters. The position peaked at $5.19M in Q2 2024. 165 funds tracked by Wall St. Rank hold DNA as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Ginkgo Bioworks position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 237,646 Ginkgo Bioworks shares in Q1 2025, an estimated $2.33M.
  • Qube Research & Technologies (QRT) first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Ginkgo Bioworks position peaked at $5.19M in Q2 2024.
  • 165 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.